相关实验视频

Updated: Jul 17, 2025

Serum and Plasma Copy Number Detection Using Real-time PCR
09:21

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on: December 15, 2017

11.4K

血清细胞外囊中的H19反映了CRPC患者中对AR轴向治疗的耐药性

Taku Kato1,2, Kyojiro Kawakami3, Kosuke Mizutani4

  • 1Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University School of Medicine, Toyoake, Japan; taku.kato.cp@fujita-hu.ac.jp.

Cancer genomics & proteomics
|August 29, 2023
PubMed
概括

血清细胞外囊长非编码RNA H19 (EV-H19) 在抵抗割的前列腺癌 (CRPC) 患者中升高,这些患者对雄激素受体轴向治疗 (ARAT) 具有抗性. 在CRPC中,EV-H19可以作为ARAT抗性的生物标志物.

关键词:
在CRPC中使用CRPC.H19 H19 是一种H19病毒.前列腺癌是什么意思 前列腺癌是什么意思通过RNA测序进行RNA测序.针对雄激素受体轴的向疗法细胞外囊泡中的细胞外囊泡.

更多相关视频

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.5K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.9K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K